Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors.
Andersson HO, Fridborg K, Löwgren S, Alterman M, Mühlman A, Björsne M, Garg N, Kvarnström I, Schaal W, Classon B, Karlén A, Danielsson UH, Ahlsén G, Nillroth U, Vrang L, Oberg B, Samuelsson B, Hallberg A, Unge T.
Andersson HO, et al.
Eur J Biochem. 2003 Apr;270(8):1746-58. doi: 10.1046/j.1432-1033.2003.03533.x.
Eur J Biochem. 2003.
PMID: 12694187
Free article.